NITCHO CORPORATION

NITCHO CORPORATION

TTSE:2961
1,719.00
JPY
+300.00
(+21.14%)
5.62BMarket Cap
Nov 13Next Earn
NITCHO CORPORATION
TSE:2961
(Tokyo Stock Exchange)

Recent

price

1,719.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2019
2020
2021
2022
2023
2024
2025
TTM
JPY
3,612.75
4,083.61
4,381.28
3,485.89
3,884.12
4,143.72
4,075.58
- -
Revenue per Share
59.73
85.28
112.18
46.41
73.15
157.32
135.22
- -
Basic EPS, GAAP
92.98
165.65
256.4
-106.97
373.63
65.86
-199.62
- -
Free Cash Flow per Basic Share
26.1
27.5
30
26.3
30
25.51
39.93
- -
Dividend per Share
1,182.25
1,232.26
1,304.07
1,393.03
1,436.16
1,585.52
1,679.42
1,716.18
Book Value per Share
1,176.4
1,226.77
1,298.38
1,388.31
1,431.69
1,581.45
1,675.75
1,712.6
Tangible Book Value per Share
4
4
4
4
5
4
4
4
Basic Weighted Avg Shares
16,164
15,902
17,061
15,468
17,642
18,444
18,119
- -
Sales/Revenue/Turnover
2.3
2.9
3.89
2.22
3.07
5.74
4.66
- -
Operating Margin (%)
136
129
121
176
156
162
169
- -
Depreciation Expense
267
332
437
206
332
700
601
- -
Net Income, GAAP
29.85
31.74
34.96
37.4
38.53
34.51
33.84
- -
Effective Tax Rate (%)
1.65
2.09
2.56
1.33
1.88
3.8
3.32
- -
Profit Margin (%)
3,281
3,588
3,854
4,373
4,426
4,887
5,410
5,700
Working Capital
253
162
71
182
146
111
125
- -
LT Debt
5,290
5,513
5,835
6,327
6,523
7,037
7,474
7,655
Total Equity
- -
4.22
6.75
3.21
4.73
9.21
7.03
- -
Return on Invested Capital (%)
- -
4.55
7.17
3.16
4.83
9.77
7.88
- -
Return on Capital (%)
- -
6.15
7.7
3.39
5.17
10.33
8.29
- -
Return on Common Equity (%)

Capital Structure

JPY

•

in mil. unless spec.
Dec'24
Mar'24
Mar'26
ST Debt
230
230
120
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
4
4
4
Market Capitalization
3,147
3,263
5,620

Working Capital

JPY

•

in mil. unless spec.
Dec'24
Mar'24
Mar'26
Total Current Assets
8,881
10,887
9,560
Cash, Cash Equivalents & STI
3,348
3,212
2,566
Accounts Receivable, Net
2,740
5,654
4,136
Inventories
2,589
1,845
2,536
Total Current Liabilities
4,993
6,211
3,859
Payables & Accruals
- -
- -
- -
ST Debt
230
230
120
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
6.29%
6.22%
Free Cash Flow
- -
-207.15%
-402.73%
Net Income, GAAP
- -
27.33%
-14.15%
Sales/Revenue/Turnover
- -
2.96%
-1.76%
Total Cash Common Dividend
- -
13.08%
56.34%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2,423
6,948
- -
- -
18,444
2025
- -
- -
- -
- -
18,119
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-42.32
133.1
- -
- -
157.32
2025
- -
- -
- -
- -
135.22
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
25.51
2025
- -
- -
- -
- -
39.93
2026
- -
- -
- -
- -
- -
Business
Nitcho Corporation (TSE: 2961) manufactures and sells functional food products, including bonito and kelp stock extracts, seaweed seasonings, and health supplements under its core "Nitcho" brand. The company offers a range of bonito-based products such as powdered and liquid dashi stocks, furikake rice seasonings, and tsukudani simmered delicacies; kelp-derived items including granular kombu seasonings and instant miso soups; and functional foods like collagen peptides, DHA supplements, and low-sugar sweeteners. It also provides private-label manufacturing services for food processors and retailers, focusing on natural ingredient processing using proprietary extraction technologies. Founded in 1917 and headquartered in Yaizu, Shizuoka Prefecture, Japan, Nitcho operates primarily in the domestic Japanese market through wholesale distribution to supermarkets, convenience stores, and food service providers, with limited exports to Asia. The company segments its business into functional foods, stock extracts, and seaweed products, targeting health-conscious consumers and professional kitchens seeking umami-rich, additive-free ingredients. In recent developments, Nitcho launched new health-oriented product lines, including plant-based bonito alternatives and expanded collagen supplement ranges in 2024 to capitalize on wellness trends. It formed a strategic partnership with a major Japanese retailer for exclusive private-label dashi products in early 2025, enhancing distribution reach. No major acquisitions, funding rounds, or reorganizations have been reported in the last two years.